Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Azn Astrazeneca Graphic](https://lunarcrush.com/gi/w:26/t:azn-astrazeneca.png) Azn Astrazeneca

AstraZeneca's Baxdrostat trial shows positive results, while an experimental drug faces a setback. Investors are watching for the impact on the company's stock.

### About Azn Astrazeneca
A pharmaceutical company specializing in oncology advancements.  

### Insights [#](/topic/azn-astrazeneca/insights)
- azn astrazeneca engagements is up XXXXXX% from the previous week.
- azn astrazeneca Engagements hit a high of XXX for the day
- azn astrazeneca Engagements hit an all time of XXX for the day

### Engagements: XX [#](/topic/azn-astrazeneca/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:azn-astrazeneca/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/azn-astrazeneca/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XXX +271%  
**1 Month**: XXXXX +33%  
**1-Year High**: XXX on 2025-07-14  
**1-Year Low**: X on 2025-03-30  

| Social Network | YouTube | X  |
| -------------- | ------- | -  |
| Engagements    | XX      | XX |
  

  
  
### Mentions: X [#](/topic/azn-astrazeneca/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:azn-astrazeneca/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/azn-astrazeneca/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: X -XX%  
**1 Month**: XX -XX%  
**1-Year High**: X on 2025-04-09  
**1-Year Low**: X on 2025-03-24  

| Social Network | YouTube | X |
| -------------- | ------- | - |
| Mentions       | X       | X |
  

  
  
### Creators: X [#](/topic/azn-astrazeneca/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:azn-astrazeneca/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/azn-astrazeneca/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning Azn Astrazeneca in the last XX hours which is up XX% from X in the previous XX hours
**Daily Average**: X  
**1 Week**: X -XX%  
**1 Month**: X +13%  
**1-Year High**: X on 2025-04-02  
**1-Year Low**: X on 2025-03-24  

**Top assets mentioned**
In the posts about Azn Astrazeneca in the last XX hours

[AstraZeneca PLC (AZN)](/topic/$azn)

**Top topics mentioned**
In the posts about Azn Astrazeneca in the last XX hours

[manat](/topic/manat), [$azn](/topic/$azn), [stocks](/topic/stocks), [investment](/topic/investment), [stocks healthcare](/topic/stocks-healthcare), [approved](/topic/approved), [canada](/topic/canada), [$hcm](/topic/$hcm), [china](/topic/china), [acquisition](/topic/acquisition), [$cinc](/topic/$cinc)

### Top Social Posts [#](/topic/azn-astrazeneca/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$AZN experimental drug for transthyretin amyloidosis did not meet its main goal in a late-stage trial dealing a setback in the race for rare disease treatments: #AstraZeneca #ClinicalTrials #PharmaNews #Biotech #HealthUpdate"  
[@BioMedWire](/creator/x/BioMedWire) on [X](/post/tweet/1945544045796762094) 2025-07-16 18:00:21 UTC 1296 followers, XX engagements


"$AZN #Astrazeneca Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension. $CINC acquisition (January 2023) pays off"  
[@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944714969359978990) 2025-07-14 11:05:54 UTC 4839 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Azn Astrazeneca Graphic Azn Astrazeneca

AstraZeneca's Baxdrostat trial shows positive results, while an experimental drug faces a setback. Investors are watching for the impact on the company's stock.

About Azn Astrazeneca

A pharmaceutical company specializing in oncology advancements.

Insights #

  • azn astrazeneca engagements is up XXXXXX% from the previous week.
  • azn astrazeneca Engagements hit a high of XXX for the day
  • azn astrazeneca Engagements hit an all time of XXX for the day

Engagements: XX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX +271%
1 Month: XXXXX +33%
1-Year High: XXX on 2025-07-14
1-Year Low: X on 2025-03-30

Social Network YouTube X
Engagements XX XX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X -XX%
1 Month: XX -XX%
1-Year High: X on 2025-04-09
1-Year Low: X on 2025-03-24

Social Network YouTube X
Mentions X X

Creators: X #


Creators Line Chart
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning Azn Astrazeneca in the last XX hours which is up XX% from X in the previous XX hours Daily Average: X
1 Week: X -XX%
1 Month: X +13%
1-Year High: X on 2025-04-02
1-Year Low: X on 2025-03-24

Top assets mentioned In the posts about Azn Astrazeneca in the last XX hours

AstraZeneca PLC (AZN)

Top topics mentioned In the posts about Azn Astrazeneca in the last XX hours

manat, $azn, stocks, investment, stocks healthcare, approved, canada, $hcm, china, acquisition, $cinc

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$AZN experimental drug for transthyretin amyloidosis did not meet its main goal in a late-stage trial dealing a setback in the race for rare disease treatments: #AstraZeneca #ClinicalTrials #PharmaNews #Biotech #HealthUpdate"
@BioMedWire on X 2025-07-16 18:00:21 UTC 1296 followers, XX engagements

"$AZN #Astrazeneca Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension. $CINC acquisition (January 2023) pays off"
@doepke_michel on X 2025-07-14 11:05:54 UTC 4839 followers, XXX engagements

Azn Astrazeneca
/topic/azn-astrazeneca